8.3
미카엘리스-멘텐 반응속도론은 약물 대사에서 용량 제한 동역학을 설명하는 기본 모델입니다. Vmax와 KM을 핵심 매개변수로 하여 시간에 따른 혈장 약물 농도 Cp의 감소 속도에 대한 통찰력을 제공합니다.
Vmax는 달성 가능한 최대 과정 속도를 나타내는 반면, 미카엘리…
Michaelis-Menten 방정식은 약물 대사에서 용량 제한 역학을 설명합니다.
이는 Vmax 및 KM을 주요 매개변수로 사용하여 시간 경과에 따른 약물 농도의 감소 속도를 결정합니다.
Vmax는 최대 공정 속도이고 KM, Michaelis 상수는 이 최대 속도의 절반에서 약물 농도를 나타냅니다.
K, M, P 사이의 관계, 혈장 약물 농도에 따라 세 가지 시나리오가 발생합니다.
KM이 CP와 같을 때 공정 속도는 최대값의 절반입니다.
KM이 Cp보다 클 때, 공정 속도는 일반적으로 대부분의 약물에서 치료 수준의 1차 제거를 모방합니다.
KM이 Cp보다 작으면 프로세스는 0차 제거와 유사한 일정한 속도를 유지합니다. 살리실레이트 및 페니토인과 같은 특정 약물은 높은 치료 용량으로 제로 차수 동역학에 따라 간 혼합 기능 산화효소를 포화시킵니다.
Michaelis-Menten 플롯은 농도에 따른 초기 선형 속도 증가, 더 높은 농도에서 혼합 순서로 전환, 마지막으로 Vmax에서 고원에 도달하는 것을 보여줍니다.
View the full transcript and gain access to JoVE Core videos
Q1: What do Vmax and KM represent in the Michaelis-Menten equation?
Vmax is the maximum process rate at which drug metabolism occurs, representing the saturation point of metabolic enzymes. KM, the Michaelis constant, indicates the drug concentration at which the process rate reaches half its maximum value. Together, these parameters define the capacity-limited kinetics of drug elimination.
Q2: How does drug concentration affect elimination rate in nonlinear pharmacokinetics?
When drug concentration (Cp) is much lower than KM, elimination follows first-order kinetics, with rate proportional to concentration. As Cp approaches and exceeds KM, kinetics transition to mixed-order, then zero-order elimination at high concentrations. At zero-order, the elimination rate becomes constant and independent of drug concentration.
Q3: Why do certain drugs like phenytoin and salicylates show different kinetics at higher doses?
At therapeutic doses, phenytoin and salicylates follow first-order elimination. However, at elevated doses, these drugs saturate hepatic mixed-function oxidases, the enzymes responsible for their metabolism. This saturation shifts their kinetics to zero-order elimination, where the metabolic rate plateaus regardless of further dose increases.
Q4: What does the Michaelis-Menten plot reveal about drug metabolism?
The Michaelis-Menten plot illustrates how elimination rate changes with drug concentration. It shows an initial linear increase at low concentrations, transitions to mixed-order kinetics at intermediate concentrations, and reaches a plateau at Vmax. This graphical representation demonstrates the shift from first-order to zero-order elimination patterns.
Q5: What is the relationship between KM, Cp, and process rate?
When KM equals Cp, the process rate operates at exactly half its maximum capacity. If KM exceeds Cp, the process mimics first-order elimination typical of most drugs at therapeutic levels. Conversely, when KM is less than Cp, the process maintains a constant rate similar to zero-order elimination.
Q6: How does capacity-limited kinetics differ from linear drug elimination?
Capacity-limited kinetics, described by the Michaelis-Menten equation, accounts for enzyme saturation during drug metabolism. Unlike linear first-order kinetics where elimination rate is always proportional to concentration, capacity-limited kinetics show variable elimination rates depending on whether metabolic enzymes are saturated or unsaturated.
Q7: When does the Michaelis-Menten equation apply to drug metabolism?
The Michaelis-Menten equation applies when drug metabolism is limited by enzyme capacity rather than drug availability. This occurs particularly with drugs that saturate hepatic enzymes at therapeutic or elevated doses. Understanding when this equation applies helps predict how elimination rate changes across different dose ranges and plasma concentrations.